David Brunel

Mr. Brunel joined KromaTiD’s Board in 2019 and severs as Chairman. Mr. Brunel was a co-founder and CEO of Biodesix from 2006 to 2020, a company that develops and commercializes non-invasive blood-based molecular diagnostic tests for oncology. Prior to Biodesix, Mr. Brunel was co-founder and President of SomaLogic, a company creating protein capture arrays for sensitive, high-throughput, quantitative diagnostics. He was also founder and CEO of Unidata, Inc. which merged with Vmark Software to create Ardent Software, Inc., where he was CEO. He served as CEO of both Codestream, Ltd, acquired by Blue Phoenix Solutions, and eMotion, Inc., acquired by Corbus, and now part of Getty Images. Additionally, Mr. Brunel serves on the board of Anark Corporation, AmideBio, HepQuant, and InOn Health. David has a BS in Chemistry from Colorado State University, and MA in International Studies from Denver University.